PropertyValue
?:abstract
  • The development of effective vaccines against the SARS-CoV-2 is considered a higher global public health priority to control the transmission and spread of the disease Different approaches have been proposed to design and develop vaccines for COVID-19, these include epitope-based peptide vaccines, recombinant protein vaccines, viral vector vaccines, nucleic acid-based vaccines, and inactivated vaccines However, until May 2020, there is not approved vaccine against COVID-19
is ?:annotates of
?:creator
?:journal
  • Acta_Pediatrica_De_Mexico
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Development of vaccines against SARS-CoV-2
?:type
?:who_covidence_id
  • #664405
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/yo1nys23>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/yo1nys23>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all